Work

Randomized, Placebo-Controlled Phase II Study of Vandetanib Plus Docetaxel in Previously Treated Non–Small-Cell Lung Cancer

Year: 2007

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2006.10.5122

Authors: John V. Heymach, Bruce E. Johnson, Diane Prager, Edit Csada, Jaromír Roubec, Miloš Pešek, Irena Špásová, Chandra P. Belani, István Bodrogi, Shirish Gadgeel, Sarah J. Kennedy, Jeannie Hou, Roy S. Herbst

Institutions: University of Pittsburgh, Wayne State University, Charles University, University of Szeged, Ronald Reagan UCLA Medical Center, UCLA Medical Center, University Hospital Ostrava, The Barbara Ann Karmanos Cancer Institute, Dana-Farber Cancer Institute, National Institute of Oncology

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2127809030

FWCI: 37.96

Cites: 31

Cited by: 292

Related to: 10